• Mashup Score: 0

    Hiromichi Shirasu, MD, Shizuoka Cancer Center, Shizuoka, Japan, discusses findings of a molecular subgroup analysis of the CIRCULATE-Japan study, identifying…

    Tweet Tweets with this article
    • Hiromichi Shirasu (@hiro_shirasu) of the Shizuoka Cancer Center discusses monitoring MRD by ctDNA in resectable CRC ๐Ÿ‘จโ€โš•๏ธ๐Ÿ”ฌ Watch here ๐Ÿ‘‰https://t.co/jyP1ydntqL๐Ÿ‘ˆ @myESMO #WorldGI2021 #GIsm #CRCsm #Oncology

  • Mashup Score: 0

    Paolo Manca, MD, Istituto Nazionale dei Tumori Milano, Milano, Italy discusses the update results from the VALENTINO trial; a Phase…

    Tweet Tweets with this article
    • Paolo Manca (@paomanca) of @IstTumori talks on the VALENTINO trial and VAF as prognostic marker in mCRC ๐Ÿ‘จโ€โš•๏ธ๐ŸŽฅ Watch here ๐Ÿ‘‰https://t.co/sxFuLWJ9lO๐Ÿ‘ˆ @myESMO #WorldGI2021 #GIsm #CRCsm #Oncology

  • Mashup Score: 1

    Lei Deng, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses the prognostic and predictive role of preoperative chemotherapy sensitivity…

    Tweet Tweets with this article
    • Lei Deng of @RoswellPark talks on adjuvant chemotherapy in gastric adenocarcinoma ๐Ÿ‘จโ€โš•๏ธ๐Ÿ“ฃ Watch here ๐Ÿ‘‰https://t.co/5ItsnRyRQ8๐Ÿ‘ˆ @myESMO #WorldGI2021 #GIsm #STCsm #Oncology